These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival. Holmlund C; Haapasalo H; Yi W; Raheem O; Brännström T; Bragge H; Henriksson R; Hedman H Neuropathology; 2009 Jun; 29(3):242-7. PubMed ID: 18992012 [TBL] [Abstract][Full Text] [Related]
3. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival. Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366 [TBL] [Abstract][Full Text] [Related]
4. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas. Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555 [TBL] [Abstract][Full Text] [Related]
5. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients. Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418 [TBL] [Abstract][Full Text] [Related]
6. Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma. Muller S; Lindquist D; Kanter L; Flores-Staino C; Henriksson R; Hedman H; Andersson S Int J Oncol; 2013 Jan; 42(1):247-52. PubMed ID: 23165628 [TBL] [Abstract][Full Text] [Related]
7. Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma. Söling A; Sackewitz M; Volkmar M; Schaarschmidt D; Jacob R; Holzhausen HJ; Rainov NG Clin Cancer Res; 2005 Jan; 11(1):249-58. PubMed ID: 15671553 [TBL] [Abstract][Full Text] [Related]
8. Expression of leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins in human ependymoma relates to tumor location, WHO grade, and patient age. Yi W; Haapasalo H; Holmlund C; Järvelä S; Raheem O; Bergenheim AT; Hedman H; Henriksson R Clin Neuropathol; 2009; 28(1):21-7. PubMed ID: 19216216 [TBL] [Abstract][Full Text] [Related]
10. Geminin: a good prognostic factor in high-grade astrocytic brain tumors. Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828 [TBL] [Abstract][Full Text] [Related]
11. Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Godard S; Getz G; Delorenzi M; Farmer P; Kobayashi H; Desbaillets I; Nozaki M; Diserens AC; Hamou MF; Dietrich PY; Regli L; Janzer RC; Bucher P; Stupp R; de Tribolet N; Domany E; Hegi ME Cancer Res; 2003 Oct; 63(20):6613-25. PubMed ID: 14583454 [TBL] [Abstract][Full Text] [Related]
12. Identification of MG-160, a FGF binding medial Golgi sialoglycoprotein, in brain tumors: an index of malignancy in astrocytomas. Yamaguchi F; Morrison RS; Gonatas NK; Takahashi H; Sugisaki Y; Teramoto A Int J Oncol; 2003 May; 22(5):1045-9. PubMed ID: 12684670 [TBL] [Abstract][Full Text] [Related]
13. Effect of RNAi-mediated LRIG3 gene silencing on proliferation of glioma GL15 cells and expression of PCNA and Ki-67. Cai MJ; Xie RF; Han L; Chen RD; Wang BF; Ye F; Guo DS; Lei T Ai Zheng; 2009 Jan; 28(1):1-4. PubMed ID: 19448407 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) in HP75 pituitary adenoma cell line. Guo D; Han L; Shu K; Chen J; Lei T J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):91-4. PubMed ID: 17393120 [TBL] [Abstract][Full Text] [Related]
15. Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival. Järvelä S; Helin H; Haapasalo J; Järvelä T; Junttila TT; Elenius K; Tanner M; Haapasalo H; Isola J Neuropathol Appl Neurobiol; 2006 Aug; 32(4):441-50. PubMed ID: 16866989 [TBL] [Abstract][Full Text] [Related]
16. Altered expression of Cx43 in astrocytic tumors. Pu P; Xia Z; Yu S; Huang Q Clin Neurol Neurosurg; 2004 Dec; 107(1):49-54. PubMed ID: 15567553 [TBL] [Abstract][Full Text] [Related]
17. EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas. Varela M; Ranuncolo SM; Morand A; Lastiri J; De Kier Joffé EB; Puricelli LI; Pallotta MG J Surg Oncol; 2004 Apr; 86(1):34-40. PubMed ID: 15048678 [TBL] [Abstract][Full Text] [Related]
18. Differences between phosphotyrosine accumulation and Neu/ErbB-2 receptor expression in astrocytic proliferative processes. Implications for glial oncogenesis. Kristt DA; Yarden Y Cancer; 1996 Sep; 78(6):1272-83. PubMed ID: 8826951 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of LRIG3 gene expression via RNA interference modulates the proliferation, cell cycle, cell apoptosis, adhesion and invasion of glioblastoma cell (GL15). Cai M; Han L; Chen R; Ye F; Wang B; Han F; Lei T; Guo D Cancer Lett; 2009 Jun; 278(1):104-12. PubMed ID: 19200647 [TBL] [Abstract][Full Text] [Related]
20. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas. Li H; Wang Q; Gao F; Zhu F; Wang X; Zhou C; Liu C; Chen Y; Ma C; Sun W; Zhang L Oncol Rep; 2008 Sep; 20(3):573-9. PubMed ID: 18695908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]